V324 Dialyzer test methods, set before clinical use
Written V0324 on the CMS-2567 and in QCOR.
Cited on this tag? What happens after a citation · One-page sheet for the binder
The regulation
ANSI/AAMI RD47:2002/A1:2003 Requirements as Adopted by Reference 42 CFR § 494.50 (b)(1)
7.2.2 Process control testing: methods established
7.2.2.1 Dialyzer test methods
Dialyzer test methods ([AAMI] 11.3) shall be established before clinical use of the reprocessed dialyzers.
Verification of tests should be repeated after each significant change in the reprocessing system. For automated systems, adherence to the manufacturer’s instructions can verify the tests. For manual systems, confirmation of the accuracy of total cell volume (TCV) measurement and the membrane integrity test can verify the tests.
CMS's interpretive guidance
Interpretive Guidance § 494.50(b)(1)
Process control enables users to verify that the equipment is functioning correctly. This can be achieved by testing for the expected parameters (e.g., verifying the accuracy of the TCV measurement) or by adhering to the manufacturer’s guidelines for automated equipment.
A “significant change” would include a change from a manual to an automated system, a change from one automated system to another, a change in the germicide, or a major repair of the reprocessing equipment.
https://middlemolecule.com/rulebook/tags/v324/